Cibus, Inc. (CBUS)
NASDAQ: CBUS · Real-Time Price · USD
1.345
+0.005 (0.37%)
At close: Jun 26, 2026, 4:00 PM EDT
1.360
+0.015 (1.12%)
After-hours: Jun 26, 2026, 4:10 PM EDT
Company Description
Cibus, Inc. is an agricultural biotechnology company that develops and licenses gene-edited plant traits.
The company's products enable farmers to achieve higher yields and reduce the use of chemicals, such as fungicides, insecticides and fertilizers, and offer sustainable ingredients.
it has patented core technology platform, RTDS, a scalable, standardized, end-to-end, semi-automated and high-throughput gene-editing system marketed under the Trait Machine brand name.
The company was formerly known as Calyxt, Inc. and changed its name to Cibus, Inc. in June 2023. Cibus, Inc. was incorporated in 2010 and is headquartered in San Diego, California.
Cibus, Inc.
| Country | United States |
| Founded | 2010 |
| IPO Date | Jul 20, 2017 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 118 |
| CEO | Craig Wichner |
Contact Details
Address: 6455 Nancy Ridge Drive San Diego, California 92121 United States | |
| Phone | 858 450 0008 |
| Website | cibus.com |
Stock Details
| Ticker Symbol | CBUS |
| Exchange | NASDAQ |
| Stock Type | Common Stock |
| Share Class | Class A Shares |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001705843 |
| CUSIP Number | 17166A100 |
| ISIN Number | US17166A1016 |
| Employer ID | 27-1967997 |
| SIC Code | 2870 |
Key Executives
| Name | Position |
|---|---|
| Dr. Peter R. Beetham B.Sc., Ph.D. | Co-Founder, Interim Chief Executive Officer, President, Chief Operating Officer and Director |
| Dr. Gregory F. Gocal Ph.D. | Co-Founder, Chief Scientific Officer and Executive Vice President |
| Rory Balfour Riggs M.B.A. | Co-Founder and Director |
| Jason Stokes Esq., J.D. | Chief Administrative Officer, General Counsel and Corporate Secretary |
| Cornelis Broos M.Sc. | Chief Financial Officer |
| Rosa Cheuk Kim J.D. | Senior Vice President of Legal |
| Dr. Noel Sauer Ph.D. | Senior Vice President of Research |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Jun 23, 2026 | S-8 | Securities to be offered to employees in employee benefit plans |
| Jun 23, 2026 | S-8 | Securities to be offered to employees in employee benefit plans |
| Jun 9, 2026 | 8-K | Current Report |
| Jun 5, 2026 | 8-K | Current Report |
| May 22, 2026 | EFFECT | Notice of Effectiveness |
| May 22, 2026 | 424B3 | Prospectus |
| May 22, 2026 | 424B2 | Prospectus |
| May 15, 2026 | S-3 | Registration statement under Securities Act of 1933 |
| May 14, 2026 | 10-Q | Quarterly Report |
| May 14, 2026 | 8-K | Current Report |